In this example, both EPR effect and the EGFR-targeting peptide contributed to targeted delivery to cancer cells, and the subsequent ROS-activated photosensitizer and release of DOX in tumor lesions further improved the dimensional precision of both PDT and chemotherapy, minimizing the side effects on normal tissues. The gene discussed is EGFR; the disease is cancer.